Cargando…
Advances in the treatment of type 2 diabetes: impact of dulaglutide
The purpose of this review is to provide a review of current data of the most recently approved glucagon-like peptide (GLP)-1-receptor agonist, dulaglutide, in the treatment of type 2 diabetes. To complete this, a PubMed search was performed to identify manuscripts published from 1947 to July 2015....
Autores principales: | Thompson, Angela M, Trujillo, Jennifer M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4861603/ https://www.ncbi.nlm.nih.gov/pubmed/27217788 http://dx.doi.org/10.2147/DMSO.S75452 |
Ejemplares similares
-
Dulaglutide: an evidence-based review of its potential in the treatment of type 2 diabetes
por: Edwards, Krystal L, et al.
Publicado: (2015) -
Pharmacoeconomic analysis (CER) of Dulaglutide and Liraglutide in the treatment of patients with type 2 diabetes
por: Su, Yu, et al.
Publicado: (2023) -
Real-World Effectiveness of Dulaglutide in Patients with Type 2 Diabetes Mellitus: A Literature Review
por: Robinson, Susan, et al.
Publicado: (2020) -
Euglycemic diabetic ketoacidosis after the initiation of dulaglutide in patient with type 2 diabetes
por: Alduraibi, Rabia Khalid, et al.
Publicado: (2023) -
The effect of Dulaglutide on glycemic and weight control in patients with type 2 diabetes
por: Ruda, Alexandru Ioan, et al.
Publicado: (2023)